John Veter Firdaus Reagen Borong Saham OBAT, Telisik Detailnya
![John Veter Firdaus Reagen Borong Saham OBAT, Telisik Detailnya](https://socialstatic.fmpstatic.com/social/202502/1081897107c04ee0972880fd6afce44f.png?x-oss-process=image/resize,w_1280/quality,q_70/format,jpeg)
IDXChannel - John Veter Firdaus Reagen menambah kepemilikan sahamnya di PT Brigit Biofarmaka Teknologi Tbk (OBAT). Pemegang saham bukan pengendali itu membeli saham emiten anyar itu sebanyak 155.800 saham.
John Veter Firdaus Reagen yang merupakan warga negara Indonesia menyerok saham OBAT pada periode 4-10 Februari 2025. Dia membeli saham tersebut dalam tiga kali transaksi dengan harga Rp655-Rp705 per saham.
![John Veter Firdaus Reagen Borong Saham OBAT, Telisik Detailnya](https://socialstatic.fmpstatic.com/social/202502/cdbd7a58e052493bb4adb2475ead2b5b.png?x-oss-process=image/resize,w_1280/quality,q_70/format,jpeg)
Berdasarkan pengumuman di keterbukaan informasi BEI, transaksi pertama, John Veter Firdaus Reagen membungkus 800 saham OBAT pada 4 Februari di harga Rp655 per saham.
Kemudian membeli lagi 10.000 saham OBAT di harga Rp705 pada 7 Februari. Dan memborong 145.000 saham perseroan dengan harga Rp655 per saham pada 10 Februari 2025.
![John Veter Firdaus Reagen Borong Saham OBAT, Telisik Detailnya](https://socialstatic.fmpstatic.com/social/202502/aa9daf532b8f47e08f93e86d7708e176.png?x-oss-process=image/resize,w_1280/quality,q_70/format,jpeg)
Reprinted from Idxchannel,the copyright all reserved by the original author.
Disclaimer: The content above represents only the views of the author or guest. It does not represent any views or positions of FOLLOWME and does not mean that FOLLOWME agrees with its statement or description, nor does it constitute any investment advice. For all actions taken by visitors based on information provided by the FOLLOWME community, the community does not assume any form of liability unless otherwise expressly promised in writing.
FOLLOWME Trading Community Website: https://www.followme.com
Hot
No comment on record. Start new comment.